تحميل
NASDAQHealthcareMedical - Specialties
أحدث البيانات المتاحة
8.63 US$
+0.07 US$ · +0.82%
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
الإغلاق السابق
8.63 US$
+0.07 US$ · +0.82%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
نطاق اليوم
السعر الحالي 8.63 US$
نطاق 52 أسبوعًا
السعر الحالي 8.63 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
47
قيمة عادلة
المشاعر
56
مختلط
المخاطر
54
مخاطر أعلى من المعتاد
الزخم
36
زخم متراجع
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
نطاق اليوم
السعر الحالي 8.63 US$
نطاق 52 أسبوعًا
السعر الحالي 8.63 US$
| البند (USD) | السنة المالية 2025 |
|---|---|
| الإيرادات | 32.04 مليون USD |
| تكلفة البضاعة المباعة | 6.07 مليون USD |
| الربح الإجمالي | 25.98 مليون USD |
| البحث والتطوير | 6.52 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 65.83 مليون USD |
| نفقات التشغيل | 72.34 مليون USD |
| مصاريف الفوائد | 967.37 ألف USD |
| الاستهلاك والإطفاء | 151.66 ألف USD |
| الدخل التشغيلي | −46.37 مليون USD |
| صافي الدخل | −46.5 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI3.57 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
iShares Russell 2000 ETFIWM1.72 مليون0.00%78.74 مليار USD0.19%278.94 US$+0.49%
Vanguard Extended Market ETFVXF1.29 مليون0.00%95.4 مليار USD0.05%235 US$+0.80%
Schwab U.S. Small-Cap ETFSCHA452.59 ألف0.00%21.82 مليار USD0.03%32.79 US$+0.40%
iShares Russell 2000 Growth ETFIWO451.92 ألف0.00%13.92 مليار USD0.24%356.78 US$+0.94%
iShares Micro-Cap ETFIWC259.28 ألف0.02%1.32 مليار USD0.60%183 US$+0.11%
Vanguard Russell 2000 ETFVTWO132.61 ألف0.00%18 مليار USD0.06%112.66 US$+0.50%
Global X - Russell 2000 ETFRSSL39.99 ألف—1.42 مليار USD0.08%109.09 US$+0.21%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFSchwab U.S. Small-Cap ETFSCHAiShares Russell 2000 Growth ETFIWOiShares Micro-Cap ETFIWCVanguard Russell 2000 ETFVTWOGlobal X - Russell 2000 ETFRSSLالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
